In general, our findings support the initial theory of Ito et al. assuming that the anti-obesity effect of MCHR1 antagonists is not limited to a central action, but MCHR1 antagonists may also act peripherally in BAT (21). The gene discussed is MCHR1; the disease is obesity disorder.